← Product Code [EIH](/productcode/EIH) · K262074 # Any-Zircos (K262074) _Mediclus Co., Ltd. · EIH · Aug 21, 2026 · Dental · SESE_ **Canonical URL:** https://fda-staging.innolitics.com/device/K262074 ## Device Facts - **Applicant:** Mediclus Co., Ltd. - **Product Code:** [EIH](/productcode/EIH.md) - **Decision Date:** Aug 21, 2026 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 872.6660 - **Device Class:** Class 2 - **Review Panel:** Dental ## Indications for Use Any-Zircos is indicated for the production of inlays or onlays, 3-unit bridges and full crowns. ## Device Story Any-Zircos is a dental zirconia ceramic block (ZrO2, Y2O3, HfO2, Al2O3) used for fabricating dental restorations; specifically inlays, onlays, 3-unit bridges, and full crowns. The device is provided as discs of varying dimensions and shades. It is intended for use by licensed dentists or dental professionals. The fabrication process utilizes CAD/CAM milling technology to shape the zirconia blank into the desired dental restoration. The device is non-sterile and designed for long-term contact (>30 days) with the oral mucosa, enamel, and dentin. By providing a biocompatible, high-strength ceramic material, the device enables the creation of durable, custom-fitted dental prosthetics, benefiting patients by restoring tooth function and aesthetics. ## Clinical Evidence No clinical data. Evidence is based on non-clinical bench testing including appearance, dimension, uniformity, radioactivity, chemical solubility, flexural strength, flexural strength after accelerated aging, linear thermal expansion, and monoclinic phase per ISO 6872. Biocompatibility testing was performed per ISO 10993-5, 10, 11, and 23. ## Technological Characteristics Zirconia ceramic block (ZrO2, Y2O3, HfO2, Al2O3). Classified as Type 2, Class 4a per ISO 6872. Form factor: Discs of various widths/thicknesses. Processing: CAD/CAM milling. Non-sterile. Biocompatible for long-term oral mucosa contact. Flexural strength: 1241.1 MPa. Radioactivity: 0.00127 Bq/g. Chemical solubility: 25.9 μg/m³. ## Regulatory Identification Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish. ## Predicate Devices - LUXEN 5G ([K241151](/device/K241151.md)) - LUXEN smile ([K171585](/device/K171585.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} **U.S. FOOD & DRUG** ADMINISTRATION August 21, 2026 Mediclus Co., Ltd. Ku Da Hyeon # 1210, 134, Gongdan-Ro, Heungdeok-Gu Cheongju-Si, 28576 Republic Of Korea Re: K262074 Trade/Device Name: Any-Zircos Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder For Clinical Use Regulatory Class: Class II Product Code: EIH Dated: June 19, 2026 Received: June 22, 2026 Dear Ku Da Hyeon: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {1} K262074 - Ku Da Hyeon Page 2 Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). {2} K262074 - Ku Da Hyeon Page 3 Sincerely, JOYCE C. LIN -S for Michael Adjodha, M. Ch.E., RAC, CQIA Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3} # Indications for Use | Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | | K262074 | ? | | --- | --- | --- | --- | | Please provide the device trade name(s). | | | ? | | Any-Zircos | | | | | Please provide your Indications for Use below. | | | ? | | Any-Zircos is indicated for the production of inlays or onlays, 3-unit bridges and full crowns. | | | | | Please select the types of uses (select one or both, as applicable). | ☑ Prescription Use (21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | | ? | | Please select the age group(s) for which the device(s) is to be used. | ☐ Neonates/Newborns (Birth to < 29 days old) ☐ Infants (29 days old to < 2 years old) ☐ Children (2 years old to < 12 years old) ☐ Adolescents (12 years old to < 22 years old) ☐ Adults (22 years old and greater) | | ? | {4} MEDICLUS® E. sales@medclus.com T. +82-43-211-2877 F. +82-43-211-2866 Contact: Lydia www.mediclus.co.kr (Headquarters) No. 1210, 134 Gongdan-ro, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28576, Korea (Seoul Office) 206 Brown Stone, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea ## 510(k) Summary K262074 This summary of 510(K) information is being submitted in accordance with requirements of 21 CFR Part 807.92. Date: August 21, 2026 ### 1. Submitter/Contact Person Da-Hyeon, Ku MEDICLUS Co., Ltd. No. 1210, 134, Gongdan-ro, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea TEL : +82(43)211-2877 FAX : +82(43)211-2866 Email: ra@medclus.com ### 2. U.S Agent Priscilla Chung LK Consulting Group USA, Inc. 18881 Von Karman Ave STE 160, Irvine CA 92612 Phone: 714.202.5789 Fax: 714-409-3357 Email: juhee.c@lkconsultinggroup.com ### 3. Device - Trade Name: Any-Zircos - Common Name: Powder, Porcelain - Classification Name: Powder, Porcelain - Product Code: EIH - Regulation Number: 872.6660 ### 4. Predicate Device: 1. LUXEN 5G by DENTALMAX CO., LTD (K241151) 2. LUXEN smile by DENTALMAX CO. LTD (K171585) ### 5. Description: 510(k) summary 1 / 3 page {5} MEDICLUS® E. sales@medclus.com T. +82-43-211-2877 F. +82-43-211-2866 Contact. Lydia www.mediclus.co.kr (Headquarters) No. 1210, 134 Gongdan-ro, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28576, Korea (Seoul Office) 206 Brown Stone, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea Any-Zircos is a dental zirconia block classified as Type2, Class 4a according to ISO 6872, and is a zirconia ceramic material used for the fabrication of dental restorations such as inlays artificial teeth crowns and, bridges. Any-Zircos is available in Discs with a various width, thickness and shades. # 6. Indication for use: Any-Zircos is indicated for the production of inlays or onlays, 3-unit bridges and full crowns. # 7. Basis for Substantial Equivalence # 7.1. Comparison Chart | | | Subject Device | Predicate Device 1 | Predicate Device 2 | Equivalence evaluation | | --- | --- | --- | --- | --- | --- | | Manufacturer | | MEDICLUS Co., Ltd. | DENTALMAX CO., LTD | DENTALMAX CO., LTD | - | | Product Name | | Any-Zircos | LUXEN 5G | LUXEN smile | - | | 510k# | | - | K241151 | K171585 | - | | Product Code | | EIH | EIH | EIH | - | | Material | | ZrO2, Y2O3, HfO2, Al2O3 and other oxides | Zirconia Powder Zpex ZrO2+HfO2+Y2O3 + various color powders | Zpex Smile ZrO2+HfO2+Y2O3 and others | Similar | | Indications for Use | | Any-Zircos is indicated for the production of inlays or onlays, 3-unit bridges and full crowns. | LUXEN 5G is indicated for the production of all ceramic inlays, multi units bridges, onlays, and veneers without zirconium dioxide frameworks. | LUXEN Smile is indicated for the production of of full ceramic crowns, onlays, 3-bridges and inlay bridges (anterior and molar). | Similar | | Intended User | | Licensed Dentist or Dental Professional | Licensed Dentist or Dental Professional | Licensed Dentist or Dental Professional | Same | | Principles of Operation | | Zirconia oxide blank is a material for crowns and bridges fabricated by CAD/CAM milling. | Zirconia oxide blank is a material for crowns and bridges fabricated by CAD/CAM milling. | Zirconia oxide blank is a material for crowns and bridges fabricated by CAD/CAM milling. | Same | | Classification | | Type II Class 4a | Type II Class 5 | Type II Class 4b | Similar | | Technological Characteristics | Standard Conformed | ISO 6872 | ISO 6872 | ISO 6872 | Same | | | Uniformity | Pass | - | - | Similar | | | Radioactivity | 0.001 27 | ≤ 1.0 Bq·g -1 | - | | 510(k) summary 2 / 3 page {6} MEDICLUS® E. sales@medclus.com T. +82-43-211-2877 F. +82-43-211-2866 Contact. Lydia www.mediclus.co.kr (Headquarters) No. 1210, 134 Gongdan-ro, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28576, Korea (Seoul Office) 206 Brown Stone, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea | | (Bq/g) | | | | | | --- | --- | --- | --- | --- | --- | | | Chemical solubility (μg/m³) | 25.9 | < 100 μg/cm2 | 0 μg/m³ | | | | Flexural strength | Mean 1 241.1 | >800Mpa | 770 ± 66 MPa | | | | Linear thermal expansion coefficient | Avg 10.85 x 10⁻⁶ | - | 10.3 X 10⁻⁶K⁻¹ | | | Sterile | | Non-sterile | Non-sterile | Non-sterile | Same | | Biocompatibility | | Biocompatible | Biocompatible | Biocompatible | Same | | Classification | | Externally communicating device in oral mucosa, enamel, and dentin; and contact duration of C-long term (>30d) | Externally communicating device in oral mucosa, enamel, and dentin; and contact duration of C-long term (>30d) | Externally communicating device in oral mucosa, enamel, and dentin; and contact duration of C-long term (>30d) | Same | # 7.2. Comparison Chart The subject device has similar indications for use and the technological characteristics as the predicate device. The minor raw materials are different between the devices but the performance and the biocompatibility test results show that it does not raise new questions of safety and effectiveness. # 8. Non-Clinical Testing Performance Tests including - Appearance, Dimension, Package, Uniformity, Extraneous materials, Radioactivity, Chemical solubility, Flexural strength, Flexural strength after accelerated aging, Linear thermal expansion coefficient, Monoclinic phase in accordance with ISO 6872. Biocompatibility tests in accordance with ISO 10993-5, 10, 11 and 23. # 9. Conclusion The subject device and the predicate device have the same intended use and have the similar technological characteristics. Based on the similarities and the test results, we conclude that the subject device is substantially equivalent to the predicate device. 510(k) summary 3 / 3 page --- **Source:** [https://fda-staging.innolitics.com/device/K262074](https://fda-staging.innolitics.com/device/K262074) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com